.png)
For interventional radiologists, vascular surgeons, and interventional cardiologists.
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
Tumor Board
Treatment of hepatocellular carcinoma (HCC), like that of many other cancers, spans a spectrum from curative to...
Episode # 5 • 17 Jan 2025
Complex HCC Patients & The "Grey Zone": What To Do When You Don’t Know What To Do
with Dr. Adam Burgoyne, Dr. Zach Berman, Dr. Kirema Garcia-Reyes, Dr. Lingling Du, Dr. Sabeen Dhand
VI Episode #643
May 8, 2026
with Dr. David Johnson, Dr. Michael Barraza
Can arterial closure devices transform your OBL workflow and get patients moving sooner? In this episode of the...
ENT Episode #272
May 6, 2026
with Dr. Zachary Rubin, Dr. Basil Kahwash
From the clinic to the camera, discover how an allergist turned social media into a patient education powerhouse. On...
MSK Episode #99
May 5, 2026
with Dr. Joaquim Filho, Dr. Mateus Correa, Dr. Venkatesh Krishnasamy
Beyond the basics: anatomy, technique, and clinical pearls for the evolving world of hip embolization. In this episode...
OBGYN Episode #115
May 5, 2026
with Dr. Kimberly Kho, Dr. Amy Park
From surgery to systems to access, medicine is shaped as much by barriers to care as it is by innovation and the latest...
VI Episode #642
May 7, 2026
with Dr. Beau Toskich, Dr. Zach Berman, Dr. Venkatesh Krishnasamy
Complete pathologic necrosis (CPN) rates above 90%? This week’s BackTable episode from the 2026 HCC Creator Weekend™ is...
Cardiology Episode #34
May 5, 2026
with Dr. Abdallah El Sabbagh, Dr. Hady Lichaa
From clot to clear flow, minimally invasive aspiration devices are PAVE-ing the way for safer treatment of endocarditis...
Tumor Board Episode #58
May 5, 2026
with Dr. Craig Lockhart, Dr. Lingling Du
When first-line treatment for advanced hepatocellular carcinoma (HCC) fails and the disease progresses, what options...
Urology Episode #301
May 5, 2026
with Dr. Udit Singhal, Dr. Ruchika Talwar
Are biomarkers the missing link in personalized prostate cancer care? What is the practical role of biomarkers across...
VI Case
Apr 9, 2026
with Dr. Alex Villalobos, Dr. Nima Kokabi, Dr. Brian Funaki and Dr. Venkatesh Krishnasamy
VI Case
Apr 9, 2026
with Dr. Alex Villalobos, Dr. Nima Kokabi, Dr. Brian Funaki and Dr. Venkatesh Krishnasamy
VI Case
Apr 3, 2026
with Dr. Nima Kokabi, Dr. Brian Funaki and Dr. Venkatesh Krishnasamy
VI Case
Apr 9, 2026
with Dr. Riad Salem, Dr. Neil Mehta and Dr. Tyler Sandow
VI Case
Apr 9, 2026
with Dr. Alex Villalobos, Dr. Nima Kokabi, Dr. Brian Funaki and Dr. Venkatesh Krishnasamy
VI Case
Apr 3, 2026
with Dr. Nima Kokabi, Dr. Brian Funaki and Dr. Venkatesh Krishnasamy
VI Case
Apr 3, 2026
with Dr. Nima Kokabi, Dr. Brian Funaki and Dr. Venkatesh Krishnasamy
mockup Course
2.5 hours, 0 lessons
Tumor Board Course
2 CME/CE credits, 2.5 hours, 26 lessons
Tumor Board Course
2 CME/CE credits, 2.5 hours, 19 lessons
Focus
Say ‘no thank you’ to the algorithms and the viral distractions. Be intentional about when you’re in learning mode with the BackTable app.
Find
Finally, a podcast player that’s on your level. Find practice-changing insights across thousands of clinical topics, all curated by physician content creators.
Curate
Stay current on the conversations shaping your field. Follow the specialties, procedures, and conditions that matter to your practice.
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.